Assistive Medical Accessory
    92.
    发明申请

    公开(公告)号:US20250000601A1

    公开(公告)日:2025-01-02

    申请号:US18758523

    申请日:2024-06-28

    Abstract: Assistive medical accessories and methods for making and using assistive medical accessories are disclosed. An example assistive medical accessory may include a sterile drape configured for use with a medical device. The sterile drape may have a top surface. A visual indicator may be disposed along the top surface. The visual indicator may be configured to provide use information to a clinician using the medical device.

    Automated method of removing clog within lumen for debris removal

    公开(公告)号:US12178457B2

    公开(公告)日:2024-12-31

    申请号:US17821975

    申请日:2022-08-24

    Abstract: A debris removal system includes an elongated shaft extending from a proximal end to a distal end and including a shaft lumen, the shaft being configured to be inserted through a bodily lumen to a target surgical site, a vibration motor coupled to the elongated shaft via a vibration collar, the vibration motor including a rotatable shaft and at least one weight coupled to the rotatable shaft, the weight being asymmetrically shaped about a central axis of the shaft such that rotation of the shaft creates vibrational energy along the length of the elongated shaft to dislodge debris within the target surgical site, and a vacuum pump connected to the elongated shaft and configured to vacuum dislodged debris from the target surgical site through the shaft lumen.

    FLUID MANAGEMENT SYSTEM WITH INTEGRATED LASER FIBER COOLING

    公开(公告)号:US20240423712A1

    公开(公告)日:2024-12-26

    申请号:US18826857

    申请日:2024-09-06

    Abstract: A medical system may include: a medical device including an elongate shaft configured to access a treatment site within a patient and a handle coupled to a proximal end of the elongate shaft; a laser device including an elongate tubular member configured for insertion through a working lumen of the medical device, the elongate tubular member including a cooling channel and a laser fiber extending distally within the cooling channel; and a fluid management system including an inflow pump configured to pump fluid from a first fluid supply source through the elongate shaft to the treatment site, a cooling pump configured to pump fluid from a second fluid supply source through the cooling channel, and a controller configured to control the inflow pump and the cooling pump.

    DEVICES, SYSTEMS, AND METHODS FOR SECURING TISSUE

    公开(公告)号:US20240423625A1

    公开(公告)日:2024-12-26

    申请号:US18830928

    申请日:2024-09-11

    Abstract: The present disclosure pertains to medical devices. More particularly, the present disclosure pertains to devices, systems, and methods for securing tissue, such as a tissue defect or wound resulting from an endoscopic procedure, e.g., an endoscopic mucosal resection or submucosal dissection procedure. In one example, a device for securing tissue may include a loop portion configured to be disposed about a distal end of a delivery device in a delivery configuration and configured to be secured about the tissue in a deployed configuration. A locking member may be disposed on the loop portion. A tether portion having a proximal end extendable proximally within the delivery device and a distal portion extending from the loop portion slidably through the locking member.

    Methods for producing cardiomyocyte cells

    公开(公告)号:US12172008B2

    公开(公告)日:2024-12-24

    申请号:US17404768

    申请日:2021-08-17

    Abstract: A method for producing cardiomyocyte cells including implanting a substrate within a heart such that a first portion of the substrate is in physical contact with an endocardium and a second portion of the substrate is not in contact with the endocardium, maintaining the first portion of the substrate in contact with the endocardium for a time at least sufficient to form trabecular fibers extending between the endocardium and the second portion of the substrate, cutting away the trabecular fibers from the endocardium, cutting away the trabecular fibers from the substrate, and removing the trabecular fibers from the heart, wherein the trabecular fibers include cardiomyocyte cells.

Patent Agency Ranking